Biotech

All Articles

ArsenalBio raises $325M, rotates off of former lead property

.Arsenal Biosciences is moving on up. The tissue treatment business has added $325 thousand in ammun...

Lilly- backed weight loss biotech files IPO

.After increasing $170 thousand back in February, metabolic disease-focused BioAge Labs has actually...

Aelis' cannabis make use of drug flunks phase 2b, driving Indivior to rethink $100M choice

.Aelis Farma's hopes of getting an easy, good selection on a $one hundred thousand possibility repay...

ProKidney standstills period 3 trial not needed to have for tissue therapy permission

.ProKidney has ceased one of a set of phase 3 tests for its cell treatment for renal ailment after d...

Vaxcyte surges on 'stunning' 31-valent PCV win versus Pfizer

.Vaxcyte unveiled what professionals called "sensational" period 1/2 information for its own 31-vale...

Recursion's brain ailment trial shows insufficient documentation of effectiveness

.Recursion has actually discovered through an early test of its tech-enabled technique to medicine d...

Acepodia, Pfizer click together for chemistry-based cell therapy

.Call it a case of great chemical make up: Acepodia, a biotech based upon Nobel Prize-winning scient...

Praxis epilepsy medication lessens seizures in period 2 hearing

.Practice Preciseness Medicines has racked up another midphase succeed in epilepsy this year, with i...

Three officers surrender as Dyne messages combined records for DMD candidate

.After running away a medical hold several years back, Dyne Therapeutics has uncovered brand new per...

Arrowhead fires off stage 3 records in uncommon metabolic ailment in front of market clash with Ionis

.Arrowhead Pharmaceuticals has revealed its own hand before a prospective showdown along with Ionis,...